Tan P, Flowers F P, Araujo O E, Doering P
Drug Intell Clin Pharm. 1986 Jun;20(6):496-9. doi: 10.1177/106002808602000614.
The effect of flurbiprofen, a nonsteroidal antiinflammatory agent, on ultraviolet B-induced erythema was studied in normal volunteers. The effect of various concentrations as well as the effect of multiple applications were evaluated at 4, 8, and 24 hours after irradiation with three MEDs of ultraviolet B. Repeated applications of flurbiprofen during the four- and eight-hour periods following ultraviolet B exposure did not increase the blanching response obtained following a single treatment. A concentration dependent effect of flurbiprofen on blanching was observed with suppression of erythema increasing with increasing concentration of flurbiprofen up to 3%. Further increase in concentration up to 5% offered no added advantage. Significant differences in blanching were also observed at different postirradiation time periods. No cutaneous or systemic complications were reported during the entire study.
在正常志愿者中研究了非甾体抗炎药氟比洛芬对紫外线B诱导的红斑的影响。在用三个最小红斑量的紫外线B照射后4小时、8小时和24小时,评估了不同浓度的氟比洛芬的效果以及多次应用的效果。在紫外线B照射后的4小时和8小时期间重复应用氟比洛芬,并未增加单次治疗后获得的皮肤苍白反应。观察到氟比洛芬对皮肤苍白有浓度依赖性作用,随着氟比洛芬浓度增加至3%,红斑抑制作用增强。浓度进一步增加至5%并没有额外的益处。在不同的照射后时间段也观察到皮肤苍白有显著差异。在整个研究过程中未报告皮肤或全身并发症。